Pablo Abellán-Galiana

Associate Lecturer in Medicine

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Pablo Abellán-Galiana is an Associate Lecturer in Medicine at Universidad Cardenal Herrera-CEU, CEU Universities, Spain. His research focuses on chronic kidney disease, acromegaly, diabetes, and the effects of COVID-19 on metabolic outcomes. Recent publications include studies on vitamin D treatments, glucose metabolism after pituitary surgery, and physical activity patterns in type 1 diabetes.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Alfonso Lechuga-Sancho

Universidad de Cádiz

SPAIN

View details

Mónica Marazuela

Universidad Autónoma de Madrid

SPAIN

View details

Ana Megía

Universitat Rovira i Virgili

SPAIN

View details

Rogelio García-Centeno

Facultativo Especialista en Endocrinología. Profesor asociado Universidad Complutense de Madrid

Gunma University Hospital

SPAIN

View details

Paolo Rossetti

Hospital Universitari i Politècnic La Fe

SPAIN

View details

Ignacio Bernabeu Morón

ASSOCIATE PROFESSOR

Universidade de Santiago de Compostela

SPAIN

View details

Davide Carvalho

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pablo Abellán-Galiana

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study

Glucose metabolism outcomes after pituitary surgery in patients with acromegaly.

Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion.

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

Differences between GH and PRL co-secreting and GH-secreting pituitary adenomas. A series of 604 cases.

Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study.

Thymic Hyperplasia and Graves Disease: A Nonincidental Association

Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly

Physical activity patterns in type 1 diabetes in Spain: The SED1 study.

Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion

Percutaneous ethanol injection therapy as the first line of treatment of symptomatic thyroid cysts.

Recent developments in the management of Cushing's syndrome.

Collaborators (7)

Alfonso Lechuga-Sancho

Mónica Marazuela

Ana Megía

Rogelio García-Centeno

Paolo Rossetti

Ignacio Bernabeu Morón

Davide Carvalho

Make your next move.